Nbe-Therapeutics AG

Where the EU money came from

Funding by EU programme. Amounts are Nbe-Therapeutics AG's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Nbe-Therapeutics AG led 1 of them as coordinator. Each links to the official record.

• CARAMBAPartner

  SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease

  Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  €99ktheir share
• MABTOXCoordinator

  Generation and Evaluation of ""Next-generation"" Antibody-Toxin-Conjugates for Cancer Therapy""

  FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

  €422ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Ospedale San Raffaele SRLItaly · 1 shared project
• PNO InnovationFrance · 1 shared project
• Universidad de NavarraSpain · 1 shared project
• Westfaelische Wilhelms-Universitaet MuensterGermany · 1 shared project
• Universita Vita-Salute San RaffaeleItaly · 1 shared project
• Universitaetsklinikum Wuerzburg - Klinikum der Bayerischen Julius-Maximilians-UniversitatGermany · 1 shared project
• Bundesinstitut Fur Impfstoffe und Biomedizinische ArzneimittelGermany · 1 shared project
• Centre Hospitalier Regional et Universitaire de LilleFrance · 1 shared project
• Pno Innovation GmbHGermany · 1 shared project
• Drk-Blutspendedienst Baden-Wurttemberg-Hessen GgmbhGermany · 1 shared project
• Charles River Discovery Research Services Germany GmbHGermany · 1 shared project
• T-Curx GmbHGermany · 1 shared project
• Biomedal SLSpain · 1 shared project
• Myeloma Patients Europe AISBLBelgium · 1 shared project
• Jpt Peptide Technologies GmbHGermany · 1 shared project
• Era BiotechSpain · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• cells technologies
• gene therapy
• genetics
• immunotherapy
• leukemia
• oncology
• pharmaceutical drugs